Payers are always wary about funding new treatments for illnesses and conditions: When millions of dollars are at stake, payers want demonstrated improvements in outcomes. So do doctors and patients, before they go through…
Continue Reading
What You Should Know:
– Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka), a global pharmaceutical company, and Verily Life Sciences LLC (Verily), a precision health technology company, have teamed up to launch a groundbreaking research…
Continue Reading
Verily, a pioneering force in healthcare, is revolutionizing the industry through its strategic integration of AI and data science. Led by Chief Medical and Science Officer Andrew Trister, the company collaborates with tech giant…
Continue Reading
Digital diabetes management tools fail to provide meaningful clinical benefits and increase health spending, a new report from the Peterson Health Technology Institute (PHTI) shows.
This is PHTI’s inaugural report after launching in July as…
Alphabet’s life science subsidiary Verily announced a strategic restructuring last year, shifting its focus to using AI and data science to improve precision health options. Andrew Trister, chief medical and science officer at Verily, sat…
Continue Reading
Myoung Cha, Chief Product Officer at Verily
What You Should Know:
– Verily, an Alphabet precision health technology company appoints Myoung Cha as Chief Product Officer.
– As Chief Product Officer at Verily, Cha will lead strategy…
Continue Reading
Brings Total Raised to Over $42 Million
Co-Founder of Nexus NeuroTech and Former Verily President of Medical Devices Jordi Parramon Joins as New Board Member
Rune Labs, a precision neurology software and data company, today announced a…
What You Should Know:
– Georgiamune, a privately held, clinical stage biotechnology company, and Verily, an Alphabet precision health technology company forms a strategic partnership to advance novel therapeutics for patients with cancer.
– Through this…
Continue Reading
The MedCity Moves Podcast has returned with another episode. We discuss some of the executive appointments occurring in the healthcare world over the past month — including new leaders at Cleveland Clinic, UnitedHealth Group and…
Continue Reading
More than 1,300 oncology drugs are in the development pipeline, waiting to potentially embark on the long journey toward their commercial debut. This journey is usually an arduous one, made even more difficult by…
Continue Reading
